https://ema.europa.eu

European Medicines Agency (EMA)The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines.European Medicines Agency (EMA) Skip to main content SearchMain navigationMedicinesFind medicineTherapeutic areas: latest updatesDownload medicine dataWhat we publish on medicines and whenMedicines under evaluationNational registersHuman regulatoryOverviewResearch and developmentMarketing authorisationPost-authorisationMedical devicesHerbal productsVeterinary regulatoryOverviewResearch and developmentMarketing authorisationPost-authorisationCommitteesOverviewHow the committees workCHMPCVMPPRACCOMPHMPCCATPDCOWorking parties and other groupsNews & eventsOverviewNewsEventsWhat's newCommittee highlightsPublicationsPress and social mediaOpen consultationsRSS feedsPartners & networksOverviewEU partnersInternational activitiesPatients and consumersHealthcare professionalsPharmaceutical industryNetworksHealth technology assessment bodiesAbout usOverviewWhat we doWho we areHow we workFeesSupport to SMEsAnnual reports and work programmesHistory of EMACareersProcurementGlossariesAbout this websiteData protection and privacyContactsCOVID-19 COVID-19 All info hereQuick linksCOVID-19 vaccines: key factsCOVID-19 medicinesGuidance for developers and companiesCoronavirus disease (COVID-19)PreviousNextEMA recommends suspension of sickle cell disease medicine OxbrytaMeasure taken as precaution while review of emerging data is ongoingRead recommendationHuman medicines committee meeting: September 2024 highlightsCHMP recommends 8 new medicines for approval in the EURead highlightsMpox vaccine Imvanex (MVA-BN) recommended for use in adolescentsVaccine assessment can support African regulators during ongoing mpox outbreakRead news on ImvanexNew chair for human medicines committeeBruno Sepodes begins his mandate on 21 SeptemberRead about new chairArtificial intelligence in medicine regulation: Guiding principles on use of large language modelsHow to ensure safe, responsible and effective useRead guiding principlesEU actions to tackle shortages of GLP-1 receptor agonistsNew recommendations to ensure these medicines reach those who need them mostRead recommendations Faster access to clinical trial information in EuropeRevised transparency rules for Clinical Trials Information System (CTIS) have become applicableRead news on CTISFind medicine Find information on centrally authorised medicines What's new Find all new and updated information published on our website in one place FAQs Find answers to the most frequent asked questions we receive Latest newsEMA recommends suspension of sickle cell disease medicine OxbrytaMeasure taken as precaution while review of emerging data is ongoing26 September 2024Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 20248 new medicines recommended for approval; another 12 medicines recommended for extension of their therapeutic indications23 September 2024EMA recommends extending indication of mpox vaccine to adolescents Vaccine assessment can support African regulators in fight against ongoing outbreak19 September 2024EMA’s human medicines committee elects new ChairBruno Sepodes begins his three-year mandate on 21 September 202418 September 2024New chair elected for EMA’s Orphan Medicinal Products CommitteeTim Leest begins his three-year mandate on 16 September16 September 2024Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 10-12 September 2024Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.13 September 2024SEE ALL NEWSEvents30 Sep2024Pharmacovigilance Risk Assessment Committee (PRAC): 30 September - 3 October 2024The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use. European Medicines Agency, Amsterdam, the Netherlands Start date: 30 September 2024 End date: 3 October 2024 03 Oct2024Management Board meeting: 3 October 2024The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance. European Medicines Agency, Amsterdam, the Netherlands Start date: 3 October 2024 End date: 3 October 2024 04 Oct2024SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data GovernanceThis is webinar for SPOR and xEVMPD during which EMA’s SPOR team will cover all aspects of regulatory data management and the way SPOR and xEVMPD work today. Online European Medicines Agency, Amsterdam, the Netherlands Live broadcast Start date: 4 October 2024, 10:00 (CEST) End date: 4 October 2024, 12:00 (CEST) 07 Oct2024Second European Medicines Agency and COCIR bilateral meetingThis meeting between European Medicines Agency (EMA) and COCIR is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. European Medicines Agency, Amsterdam, the Netherlands Start date: 7 October 2024 End date: 7 October 2024 07 Oct2024Virtual live hands-on training course for clinical trials sponsors using EudraVigilance systemEudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of... Online Start date: 7 October 2024 End date: 9 October 2024 07 Oct2024SPOR and xEVMPD Stakeholder Engagement Webinars : Referentials Management Service (RMS)This is a webinar for SPOR and xEVMPD during which EMA’s SPOR team will cover all aspects of regulatory data management and the way SPOR and xEVMPD work. Online European Medicines Agency, Amsterdam, the Netherlands Live broadcast Start date: 7 October 2024, 10:00 (CEST) End date: 7 October 2024, 12:00 (CEST) SEE ALL EVENTS Information for you Patients and carers Featured news and updates for patients and carers. Healthcare professionals Featured news and updates for healthcare professionals, including doctors, nurses and pharmacists. Animal health professionals Featured news and updates for animal health professionals and users of veterinary medicines such as pet owners. Pharmaceutical Industry Featured news and updated for pharmaceutical industry stakeholders active in the human and veterinary medicines fields. Media Featured news and updates for journalists Academia Featured news and updated for European Academics and researchers in the field of medicine development. Back to topProduct emergency hotlineOUTSIDE WORKING HOURSAbout usWhat we doCareersCommittees & working partiesRegulatory networkEuropean expertsLanguagesFrequently asked questionsGlossariesAbout this websitePrivacyCookiesSearch tipsAccess to documentsContactsSend a questionEMA Service Desk (system support)Services and databasesEuropean Medicines AgencyDomenico Scarlattilaan 61083 HS AmsterdamThe NetherlandsTel: +31 (0)88 781 6000How to find usPostal address and deliveriesBusiness hours and holidays RSS Feed X YouTube LinkedIn © 1995 - 2024 European Medicines Agency European Union agencies network An agency of the European Unionenen1729222429https://ema.europa.eu

Hlela isayithi yakho?

Wentani?